Health • May 20, 2026
New drug approach offers hope for patients with recurrent aggressive cancers
Originally published on Fox News Health
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Originally published on Fox News Health.
More good news
- Amid Spokane fires, local bootmaker turns headquarters into refuge for firefighters, distributes new shoes for free
- Town’s Beloved Santa Claus Delivers a Very Special Present to Someone in Need–His Donated Kidney
- That time you learn you've been lying to yourself.
- Man recreates a 30 years photo of him and his dad, with his son